Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Apr 28;13(12):2118–2127. doi: 10.1016/j.cgh.2015.04.024

Table 2.

Comparison of hepatopulmonary syndrome and portopulmonary hypertension

Hepatopulmonary syndrome Portopulmonary hypertension
Prevalence in cirrhotic patients 10–33% 5–10%
Portal hypertension Usually present Always present
Pulmonary vasculature changes Vasodilation and angiogenesis in alveolar regions Arterial thickening and remodeling in resistance vessels
Hypoxemia Always present Sometimes present
Echocardiographic findings Left atrial bubbles 4–6 cardiac cycles after injection of agitated saline Elevated pulmonary artery systolic pressure
Indication for transplantation Indication; increased prioritization for patients meeting specific criteria Increased prioritization for patients with mild disease controlled by POPH therapy; contraindication if severe,
Improves with transplantation Always Variable